Active substance
Results for the substance dabrafenib
3 results
About this active substance
Dabrafenib is a medication used for the treatment of certain types of cancer, such as metastatic or unresectable melanoma, that have the BRAF V600 mutation. It acts as a BRAF kinase inhibitor, blocking signals that promote cancer cell growth.
The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's response and any adverse reactions. Common side effects include fever, fatigue, nausea, and skin rashes.
Dabrafenib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with hepatic or renal conditions.
This medication is an important option for patients with advanced cancer, helping to slow disease progression and improve quality of life.
The medication is taken orally, usually twice daily, with the dose adjusted based on the patient's response and any adverse reactions. Common side effects include fever, fatigue, nausea, and skin rashes.
Dabrafenib is contraindicated in patients with hypersensitivity to the active substance or any of its excipients. It should also be used with caution in patients with hepatic or renal conditions.
This medication is an important option for patients with advanced cancer, helping to slow disease progression and improve quality of life.
-
-
TAFINLAR 50mg capsules EUROPHARM ORIGINAL MEDICINE
-
FINLEE 10mg dispersible tablets EUROPHARM ORIGINAL MEDICINE